<SEC-DOCUMENT>0001144204-15-053727.txt : 20150904
<SEC-HEADER>0001144204-15-053727.hdr.sgml : 20150904
<ACCEPTANCE-DATETIME>20150903194408
ACCESSION NUMBER:		0001144204-15-053727
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20150901
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20150904
DATE AS OF CHANGE:		20150903

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ATOSSA GENETICS INC
		CENTRAL INDEX KEY:			0001488039
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				264753208
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35610
		FILM NUMBER:		151093164

	BUSINESS ADDRESS:	
		STREET 1:		2345 EASTLAKE AVENUE EAST
		STREET 2:		SUITE 201
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206.588.0256

	MAIL ADDRESS:	
		STREET 1:		2345 EASTLAKE AVENUE EAST
		STREET 2:		SUITE 201
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v419640_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES SECURITIES AND EXCHANGE
COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Date of Report (Date of Earliest Event
Reported): September 1, 2015</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Atossa Genetics Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1pt solid; text-align: center">Delaware</TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1pt solid; text-align: center">001-35610</TD>
    <TD STYLE="vertical-align: bottom; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1pt solid; text-align: center">26-4753208</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">(State or other jurisdiction of <BR>
incorporation)</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">(Commission File Number)</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">(I.R.S. Employer<BR>
Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 66%; border-bottom: black 1pt solid; text-align: center">2345 Eastlake Ave. East, Suite 201, Washington</TD>
    <TD STYLE="vertical-align: bottom; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 32%; border-bottom: black 1pt solid; text-align: center">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;98112&nbsp;</P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">(Address of principal executive offices)</TD>
    <TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: center">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Registrant&rsquo;s telephone number, including area code: (206) 325-6086</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>Not Applicable</U><BR>
Former name or former address, if changed since last report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 7%; padding-left: 0.125in"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="width: 93%; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in"><FONT STYLE="font: 10pt Wingdings">&uml;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02. Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On September 1, 2015, Scott Youmans was
appointed as the Chief Operating Officer of Atossa Genetics Inc. (the &ldquo;Company&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Youmans has no family relationships
with any other executive officers or any directors of the Company, and has no arrangements or understandings with any other persons
(other than with our directors or officers acting solely in their capacities as such) pursuant to which he was selected as an officer.
There are no transactions in which Mr. Youmans has an interest requiring disclosure under Item 404(a) of Regulation S-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with Mr. Youmans&rsquo; appointment
as Chief Operating Officer, pursuant to his promotion letter, dated as of September 1, 2015, Mr. Youmans will receive an initial
annual salary of $287,040. Mr. Youmans will also be eligible to receive an annual cash bonus in an amount up to 35% of his base
salary. On September 1, 2015, Mr. Youmans was awarded an option to purchase a total of 50,000 shares of our common stock, pursuant
to our 2010 Stock Option and Incentive Plan, as amended, with an exercise price of $0.76 per share which was the closing price
of our common stock on the Nasdaq Capital Market on September 1, 2015, the date of Mr. Youmans appointment. The option will vest
quarterly over a four-year period and will expire 10 years from the date of grant. Further, upon a change-of-control of the Company,
100% of Mr. Youmans&rsquo; then unvested options shall vest. The foregoing description of the promotion letter is qualified in
its entirety by reference to the full text of the promotion letter, which is filed as Exhibit 10.1 to this Current Report on Form
8-K and is incorporated by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with Mr. Youmans&rsquo; appointment,
we also entered into an Indemnification Agreement with Mr. Youmans&rsquo;, effective September 1, 2015, in the same form as has
previously been entered into with our other executive officers and directors. The Indemnification Agreement generally requires
us to indemnify Mr. Youmans against liabilities incurred in the performance of his duties to us to the maximum extent permitted
by applicable law. Our standard form of Indemnification Agreement is filed as Exhibit 10.5 to our Amended Registration Statement
on Form S-1 filed with the Securities and Exchange Commission on May 21, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;On September 2, 2015, the Company
issued a press release announcing Mr. Youmans&rsquo; appointment. A copy of the press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Item 9.01. Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; border-bottom: black 1pt solid">Exhibit No.</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 88%; border-bottom: black 1pt solid">Description</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Promotion Letter</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">99.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Press Release, dated September 2, 2015</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">* * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top">Date: September 3, 2015</TD>
    <TD COLSPAN="2">Atossa Genetics Inc.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%">By:</TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid">/s/ Kyle Guse</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Kyle Guse</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer, General Counsel and Secretary</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit Index</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; border-bottom: black 1pt solid">Exhibit No.</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 88%; border-bottom: black 1pt solid">Description</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">10.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Promotion Letter</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center">99.1</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Press Release, dated September 2, 2015</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B></B></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v419640_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 99%; padding: 0; font-size: 10pt; text-indent: 0"><IMG SRC="image_001.jpg" ALT=""></td>
    <TD NOWRAP STYLE="width: 1%; padding: 0; text-indent: 0">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">2345 Eastlake Ave E, Suite 201</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Seattle, WA 98102</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office: 800-351-3902</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fax: 206-430-1288</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">www.atossagenetics.com</P></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September 1, 2015</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Scott Youmans</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[******]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[******]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">*Hand Delivered</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Scott,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A significant factor in our success at Atossa Genetics
is our people and the effort and talent they bring to the workplace. In recognition of this importance, we are pleased to
inform you that you will be promoted from Sr. Vice President, Operations to Chief Operating Officer, effective September 1,
2015. This is a Section 16 Officer position and the annual rate of pay will be $287,040. In addition, you will be granted an
option to purchase  50,000 shares of Atossa Genetics common stock at the closing price on the date approved by the board,
which vests over four years of employment with no cliff. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In your time with Atossa, you have quickly
demonstrated your work ethic, dedication, and your superb qualifications. We have faith that you will continue to excel in
your new position and hope that you continue to develop your potential here at Atossa Genetics. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Congratulations on this promotion, and we look forward to
your contributions in your new position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Thank you for being such a valuable asset to Atossa
Genetics and for your loyal service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>/s/ Steven C. Quay, MD, PHD, FCAP</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Steven C. Quay, MD, PHD, FCAP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CEO and President</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1pt solid; padding-left: 0; font-size: 10pt; text-indent: 0">/s/ Scott Youmans</TD>
    <TD STYLE="width: 2%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="width: 49%; padding-top: 0; padding-right: 0; border-bottom: Black 1pt solid; padding-left: 0; font-size: 10pt; text-indent: 0">09/01/2015</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 0; font-size: 10pt; text-indent: 0">Acknowledgement of receipt &ndash; Scott Youmans</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding: 0; font-size: 10pt; text-indent: 0">Date</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v419640_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: left; margin-bottom: 0pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 103px; width: 261px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Atossa Genetics Inc. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Announces Appointment of Scott Youmans
as Chief Operating Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Seattle, Washington &ndash; September
2, 2015</B> &ndash; <B>Atossa Genetics Inc. (NASDAQ: ATOS</B>), a healthcare company focused on improving breast health through
the development of pharmaceuticals to treat breast health conditions and through commercialization of its medical devices and laboratory
tests, today announced that Scott Youmans has been appointed as Chief Operating Officer, effective September 1, 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Youmans has served as Senior Vice President, Operations
for Atossa since September 2014. He brings more than 20 years of medical device development and manufacturing experience in both
U.S. and international markets to this new role. Throughout his 20 year career, Mr. Youmans has focused on developing, manufacturing
and commercializing complex, innovative technologies in a wide variety of clinical applications including: targeted drug delivery,
peripheral vascular atherectomy, coronary atherectomy, thrombectomy, biopsy tools, and beating heart support. He brings experience
in rapid product iteration, design controls, continuous improvement, supply chain development and management, product life-cycle
management, project management, pre-clinical studies, clinical studies and clinical field support.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&quot;We are excited to appoint Mr. Youmans to this critical
role as we move forward with our initiatives to commercialize our devices and progress down the pathway towards clinical trials
of our lead pharmaceutical drug candidate, Afimoxifene Gel,&quot; said Dr. Steven C. Quay, CEO and President of Atossa. &quot;Mr.
Youmans has demonstrated the highest caliber of performance in his work as Senior Vice President of Operations and we are confident
his deep experience in device manufacturing, conducting clinical trials and developing and commercializing new products and technologies
will be instrumental in leading us to achieve our goals,&quot; he continued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to joining Atossa Genetics, Mr. Youmans directed the development
of the Precision Olfactory Delivery Device at Impel Neuropharma. From 2000-2013, Mr. Youmans held increasingly responsible roles
at Pathway Medical Technologies, including VP of Engineering since 2003. From 1999 to 2000 he was a Senior Engineer and Project
Leader developing novel technology at A-MED Systems. From 1994 to 1999 he was a Principal Engineer and Project Leader at Boston
Scientific's Northwest Technology Center. Prior to that he held technical roles in the rapid development and high volume manufacture
of precision mechanical injection molded components. Mr. Youmans holds a Bachelor of Science degree in Manufacturing Engineering
Technology from Western Washington University.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Atossa Genetics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atossa Genetics Inc. is focused on improving breast health through
the development of laboratory services, medical devices and therapeutics. The laboratory services are being developed by its subsidiary,
The National Reference Laboratory for Breast Health Inc. The laboratory services and the Company's medical devices are being developed
so they can be used as companions to therapeutics to treat various breast health conditions. For more information, please visit&nbsp;www.atossagenetics.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Forward-looking statements in this press release are subject
to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results,
including the risks and uncertainties associated with actions by the FDA, the outcome or timing of regulatory approvals needed
by Atossa to sell its products, responses to regulatory matters, Atossa's ability to continue to manufacture and sell its products,
recalls of products, the safety and efficacy of Atossa's products and services, performance of distributors and manufacturers,
whether Atossa can launch in the United States and foreign markets the additional tests, devices and therapeutics in its pipeline
in a timely and cost effective manner, and other risks detailed from time to time in Atossa's filings with the Securities and Exchange
Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time
to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Steven C. Quay, M.D., Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">President &amp; Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atossa Genetics Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Phone: (800) 351-3902</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kyle Guse</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer, General Counsel and Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Atossa Genetics Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Phone: (800) 351-3902</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Investor Relations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">CorProminence LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Scott Gordon, President</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(O) 516-222-2560</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">scottg@corprominence.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !. /H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^SG]K;]K/
M0_V3O#'ACQ3KOA+6?&$?BOQ+)X:L]-T2\L-/F@N(=)O-6FN[BZU)O*$"PV7E
MK%%')([R&0[54@_!#?\ !:'P," OP&\8NQ91@>,_#I!7!WE76Q>,E" & ;N,
MD,&4:/\ P6;D>+X6?!4HRH'^*&J%@>=[GP7JHC"@AE#$QGDJ&VDA&1FR?YZ5
M(C)$:*DA#*"Q+#YL,X)((7=]X\@@_,,DFN#&8FKAJZIQC3<'1IU+R3<W*<JJ
MDM^7E2A%JUGJU=V/[Z^C]X!>&/'WAEEG$_%&4YCCLWQF;9[AJM>AG^9Y?1]A
ME^84\)AJ<,-A;48.,.;GFFYU)-RDDVDOZ$+;_@LW\.I=QN/@KXXA8%"%M_$O
MAN[9@V=P4.ME\T9XVNP+-YBX 57-B3_@L_\ "..%W;X1_$7>JEV$&J>%9$4*
M-S9DDU"(AD3+,%3<H60KO*E:_"OX5_"7X@_&WQAI'@'X7^';[Q)XHU*2'S$M
M$==.T*R>39)K/B;56CGM=#T. 9#ZE>[1.Z_8M/BU#5I[/3KO[2CN/V;OV1IH
M-&\,Z)HW[6?[3]I-;VL_B-Q=7_P ^'?C,W4/V;2?">@6CIK'Q0UZQOG-FKJK
M>?J:6T%O/X=U^6;PZN-&MBG^^J580H_"E.$%!MWUBHQE4FUHK1N[V5M3WN+O
M!#P#R'&RR+*N&^)N)>+983Z_'A_*>,<7AZ.78&/.GFG$^?8]QRKA;)H.SJ8O
M,JSQ=6G3JK!8#$349'[A_!G]L-/B9X=U'XA^,/A9XL^!?PHLM$M=4@^(WQ@U
M[POX<T76);TPR6<&@V4E^FJ:C:W%N\MQ'K!MK?2YT6VCL;J^FO!%%R?A7]O_
M ,-?%?Q_=^!O@)\)OB1\6['2IXX-:^($%M:^%/ .DQM<"'[?=:WK;9BT\1'[
M;"UW;V=[?V:27%A97401W_*SXG:-KE[9>'OC-_P4H^+GBI(-1LY-7^&7[*_A
M7[+8_$W5)M1=KF)[SPEY%EHOPO\ "]KIBVMGJM]?K'XTD2Y31O$OBOPUXDT^
M;PQK/RS\3_VR?'_BS0)?AI\.=*T/X!? ]GN$M?A7\+!#8QZC:SQW$5R_C7Q?
M#;6WB'Q;=ZG'+;C66EGTRQU.2U*7VE32()SV5L3&E&G*;C24N7W9P<ZU1/EU
MIT8R7LXO5\]:2:334)/0_*>'/H]8+B^OCGP_A*>84ZE:KAZF>X7-,ZAX=<.O
MVCISH9+FN-P\.*?$O-\$D_:XC 8/(N%*>)52G4S'$TH0C/\ >7X[_P#!3'X"
M_!75?^$:TN:]^*OBRVEMHM7TWP'+!<:)H;S2%9(=2\6RO+I7VZ*-69M.L%U&
MZ0F)+I;/S"4^L/V>/C-IW[0GPC\*?%S2M$O_  [8^*CK/DZ+J%W;WUU9/H?B
M#5/#UPLMY:A()TFN-)EN(G2.,^3.@= X8'^+**2*+;"JF&+;Y4;)AV\HG*JW
M+!$5CE %81@F-$"DU_61_P $T7_XPS^#RAU8R-XZE8*4+1"7XA^*KA()A&\B
M+<11.D4Z)(ZI*&7>Q!K+"XN6(K58.,80C3YJ:L^>34TI.4KM+36UEI9+8Y_'
M_P "N$O"7@7A3&Y-B,US#/,;G];+LTS7,,4O9XVC'**F+_<Y;0IPPF"A'$4V
MZ?).K7]E:->I.;E(^]Z***[C^13'\0:]I7A?1=6\1:[?0:9HNA:;?:QJ^I73
MK'::=I>FVTM[J%_=2,5$=M:6D$T\TA(5(T9F( R/EW]D#]L[X1_ML>"?$_Q"
M^#8\2Q^'?"OC&3P1?Q>+]%3P[K<FHQ^&O#/B:/4(M'.HW\\.DWEMXEBM;.>Y
M,4KWFFZI \<;6WS_  G_ ,%S_P!H9OA#^QQJ?PTT74Y-.\7_ +1.LP_#:%[6
M9DNH/ D$1USXF73M!-%=6UE>^'+0>$;F[BW/N\6P6\"K-,LT/Y-_\$(/V@[_
M , ?M.^*O@=?W$1\,?M ^&7O-.C>XASI_P 1/AO;:MXBTMH$>ZB0'7_".I>+
M[74Q864KW]SHWA^3RK:VTZ5F#W,-DTZ^2XS-;RYJ%6$:5-+2=&FTL54VN^1S
MAR[*T*C5TKG]A5%-4DJI.<X'7K_2H;JXBM();F9TBA@CDEEDE=8XXXXD:222
M21R$2.-%9W=RJJJEF8 $T'AVUMUO;YWM^98) ZD#ZT5^!%I_P6(3XX_MV? #
M]G3]FZQLKSX*>(/']_H'CGXH:WH\EQ??$F+_ (1;Q)>VL?P_L+B>P;PYX-L[
MO3H+Q?%.J17&M>+'DLCI-CH^E6[MXD_?.(DH&)Z\C.,@8P!Q@=L__7YH.K%8
M/$X)T8XFE*E.M1AB(0EI-4ZCDHN<=X2?+?EDE))QNDW92444$X!)Z#DT'*%%
M-#*3@'G\?3/\N:=0 4444 %%)D$D9Y'4?6EH ***0$'.#G!P?J.U "T444 %
M%%% #'4.""H8$8(.#D>F#P1['C\<5\TS_L:_L?W<TUU=_LI?LV75U<RR7%S<
MS_ SX733W%Q,YDFGFFD\*-)+++(S2222,SN[,S,6))^F:*.EGJKWMHU?:]FF
MKVTO:]M+VT$KQESQ]V7+R<R]V7+S<W+S*TN7F2ER\W+S)2Y>9*1^*?\ P6?)
M7X5_!'&YE_X6IJ0EQG*Q_P#"$ZTWF 8P=I!W#/.<#.3G\4O@7\$/'7[07Q$T
MSX<?#^WMII[BTN-:U[Q#JKFV\/\ A3PY87%O%JGB37KN.&:2.SLQ=6\%O!%&
M;K4=0NK73K<QM.]Q!^U/_!9T%OAA\$417::7XHZM;PQJ&<RR3>"]5C6,0+_K
MI/WH*#<CDJ1')ND /P)\;;Z7]COX)6/[+7A=DM?C#\7M*T#XA?M(>-]-C-KJ
M^F>'M66^3PI\$K"[MB-6B@L+1&OO$9EOKN*\@U/6(K*RBTOQ[-:Z/YN*ITWB
MIUZ\I*A1H4.:,6VY2ESN$8Q47K-M0T;=V]+79_HOX'<39GEW@EP7PKPPZ"XP
MXJS_ (WAEV*Q=+VN7<.Y'@,VP]7/^,,T@I*-7"Y%A:L/JN%DX_VAG&+RW!IN
MG]:O)XK^,5EH^BV_[&?[#-CK.LZ!XIU)=/\ 'GQ-M;28?$?X]>++5VDU*QT2
M\(M9=!^'MF+:1;:='M[.Z\./>QV<T'A>[U#4/$6E-J_PM_X)_6*V&A+H?Q:_
M;26RDL-0U\6CZG\-/V;9[M'BO-)T>)5DA\0^.X+*Z>VN[N1U=&C5Y6T;2I1I
M.NV+N_MO^">/PUT[3["ST^[_ &R/C=X-CU2;6OL]C<1?LX?#'4UGAM(]-CO[
M:\%QXZ\7!M0BOYH9#8VVHV4<MU:7NC^%;.P\2_(?P5\'_!#QM/XFU+X^_';Q
M/\-Q87-I=I'8>!=2\>^(_']QKAU'^T;\>)I=5NH]-U32KNUM;W56US1+RYU:
M/4DF2[:ZCO(X5.LXN,(JE#$U$E"$FH0PM%Q;BU*4N7V\O=EK9KFO-*3C"7T>
M3Y#E699%F.9UL-Q)6\*:&94Z^(EEN!S'.^-?&_B7ZX\)B^).)%ED(YKB>#(X
MZC+!Y;E>%J83+\?A\+.I[+"\.4<)0Q?D7BGQ)X@\8^(==\8>,M?OM>\1^+-0
MDU?7M>U*07-_J5S=D&,2%<>3!;6PAM].L8TAM],L$@M+*WMK-(88^8D=RP>;
MS<,503!E$7E(@2&%4(+1E5X0A6S"5,C.^37W]!^RE^S1\0W-M\$_VW_",WBN
M\57T;P;\;?!&M?#9M=U"1'6ULH_&][.-/CN+N:/*KIWAO79BLD-N8_M08R?*
MOQA^!/Q9_9_\56W@SXL>'8M"UN]MY]2L)++4[;6=&UG2%GCMH=6T+6+.9DN[
M&>8R1+'>6FGZO8".);^QLY)HXU\^I0KKFKU;UFW[U6,U45WLG-7L]-;Z<S\T
MG^\<*>(?!&>XNEPUDN,J95F^#P:G1X6SC(LXX2S2E@L+2BYRP&3YWEN7/$X3
M"4XQ<Y9;+$T*-+DER0H\LY>5VJ%9O,0,P,CR[0<B1'1D+QY!*$JVY0,*'53R
M0!7]:'_!,RYEN_V,O@W,Y!"?\)U;1@)L"+;?$7Q=#Y0)FF:180C(LK%&D*Y,
M,7W!_)@(Y(RL22LZ*_S%5B#X?@*76-0,<8"H!GYB.2!_6Q_P3596_8M^"DL;
M&0&V\;.1E-JL_P 2/&2B!-BA52%2%0 O@9#.[$N>G+E)UISY4H>S5DY>]%N5
MM4U[Z<?1IV=K)G\X_38E)\$<&MN[EQ;B4V][0R"ORK2RLN>73KN^GWI4<A"H
MQ^;(7("C+?+EN%'))Q@ <DX&#3P<@$C!]#VKYQ_:T^.VE_LT?L\?%SXWZG]B
ME;P'X-U2_P!"L-1:6.RUSQG?QIHO@#PK,\,4CK_PEGCG5/#WAQ9<H(VU4.SJ
MB,P]H_S>A"=6<*=.+G4J3C"$5O*<Y*,4N[O+9:NUDF['Y!Z39Z%^W=_P6 ^)
M5_<);^)?@U^Q)\'/$/PAU!9;@W>DZE\2?'3^*/"GBRSETX^9;GRM3UKQMHEQ
M!>1!IKGX465_#++;KI9/\V5O<>.OV(?VIFN6V3>.?V8?C4;95>)O*UX> ?$%
MY9E88YHXYY;;QSX9A@N+7S$#2VGB&"5W$D\+U^V'_!*W]OG]C']DCX :_I'Q
MH^)OB=?C=\3?B3XF^(OQ'D'PV\?>)KJ"5HXO#NA6EQXHT;PY>6VN1W&E:*_B
MV=3>W;Z7JGC/5H[B.*Y_M&_N?S7_ ."H?Q8_9]^/G[6VJ_&C]GSQ+<^*=!^)
M/@;P0WCB75O#'B3PCJ%EX^\):=)X'F!L_$NF:4VK6%QX#T3P&\)@BN7BNK>^
MCNKJ&,VEJ _0\FAB%C\=E57#8N&65<!'!PJ/#58TW4H4FY55S6IQEB:E:NN?
MGLE"#O))6_NG\%>*M"\=>$O#/C7PS?Q:GX=\8^'=$\4Z!?PL'BO=#\0:9;:O
MI5W$PX:.XL;R"56'!##H:^'OV\?CW^TQ\(O#.DZ-^SA^RKK'[1EUXMT[Q5'X
MQUM/$6G:!X;\ :#!IBVJ27BEKS5]4UK49KZ:ZM+2/3(M+33M,O#<ZB;F>WMJ
M^>_^"(_[1 ^,G[&^B^ M:N@WC3]GS4_^%9ZG"R7+37/@V6&76/AIJAGG\P7$
M)\.22^&4GBE,9N_"=W 8XI49&_5WQ\BCP-XS98HI'/A/Q'\DPC:*0_V+>XCF
M$RR1/$QPKK*C1;2=ZLN00^&G2>"QTZ->C&H\-B94Y4JDIQC/EJ<L6W2DFTTX
MS5FXRTO=,_SZOV-?$_Q#\"_M)_ 7Q5\&?AY-\9_B+X3\13:AX)^&MQJ#:1<>
M-;[3_!GB"*2W?5K>SN);66#1CJ&O7%PMI,\WV.19(RSR.W]A?['_ .U!^W/\
M9/BKJOA3]H[]B(?LZ?#JQ\ ZKKVG?$%O'-WK<E]XULO$OA32M/\ !ZZ)=:/9
M-+#JVB:GXJUQ=2AN6:U3PS DD$D.J1W$7\J/_!)1Q_PWA^Q\H3[0\WB'5)+F
M2:5KR)V_X4_X[9I1<CS)C('-M-#<[X8;B:UE#/(+ES)_?!%''L201J&5<@X&
M1QR!C('/4#(SDCDYH/I^+ZU+ZW1I_5J<Y3P5"<*\IUE4I)SFN2,%/V-HJ-E>
M+NGS/WC$\4^*_#_@KPUKGC#Q7K6G>'?"_A?1=5\1>)-?UBZAL=*T/0M$L9M2
MU?6-3O;ATAL]/TVQMY[R\N)'"0V\,CMPF*_"[7/^"N'Q9_:9^*Y^"?\ P34^
M!NF_%34;.WU'5M;^*OQDN-1\'>$X?#.GW=MI3>)],\+37_AW4K3P_-?WUHEK
MJ'C#6-$UV]GFMK&S\ WES=1E.#_X+\?M ^)?#OA'X0_LW^&KN2UTKXGR:UX\
M^)*V\,SW&J^&_!.K:(OA30))5;[/_8]QXF-[XFU2!D%U->^#M!C64Z<VK6.H
M:?\ P;V> %TSX-?M!?$6ZL?*O?%OQ6T#P9:WLD,PENM'\!^!=(UQUAN9CF:T
M'B'X@:XRB!(XH;@7$!&^,H@>92RVGA<F><XF$*\ZM2-'"8>;E[%^TG.G[:NJ
M<Z=1J+A+EI1G'F:3DU%ZY7Q1_P""F/\ P4+_ &)_&?AG3OVROV:OA)K_ (%\
M0&:#3_$OPGU36M)@UY["U-QJ@\/>*KOQ)XKT4>(K./9>2>#_ !1X:\+W=W;A
M[FUU"UTUDNQ^R_[*_P"UI\&OVP_AM#\3?@SKMWJ6E0Z@VBZ_HFL6#Z3XF\(>
M(H;*TU&;0?$NF.\\=O=_8K^SNK.\T^[U+1=5M)EO='U74+7,P^</^"M?P7TW
MXR_L(_&NWFCA75OAEHZ_&?PS<2V\MR;?5_ATL^I:E''#%<VKM)JW@Z?Q5X>&
M'=536B\MM?6Z3:=>?S4?\$8_C7JGPC_;F\">&;>YN(/#'QVTG4OA/XULFO+Z
M2UO[V#2M9\5_#K7%M$4VLVL:1XGT?_A'[*_O78V7ASQ;XCCLVB:X:TN@Z*>5
MX;-,DQ&8X2C##8S+Y36+H4IR]C6HQ@JT:M.%5R=.?LW)-*HU>-MW9?V_2.$1
MFW  #J3P.Q/'I7XU?M)_\%4=5TKXZM^R-^QO\*8?CO\ M$RZ[?\ A"ZU#Q+J
MB>'?AGX>\6Z+;WNH^(]#DE?4M%OO%%QX6TW2M6D\5W5GK?A[0= NK"[L?[?U
M+5-,UC2[']CID?[.3%C>J$H" !N8AA_$F I /WX^.DL9&]?X"?@Q\?\ XA_L
M0_MH/\4/$WARX\0^-OAC\1OB+H7Q.\+:C.NGR>)&U2?Q/X8^(<$>KS6TZVFK
M)=W=YJ>DZQ):F-M4LX)+N.[TV_U".Y#ER/+:>8K,).FL36PV$=7"X1S<%7KR
MYU'VBBXU)4H*#<HPE%RDX+F2O?\ <KXV_P#!2#_@I9^Q%K7A'5OVMOV=?@7J
M/PR\3ZO+8_\ "2?#6]\216LEOI48O=9TZQ\2?\)CXIM=-\6C2//U+2]#\2>'
M+&+5;?3]3EL9KJRT?5[VP_HITV[M]0L+34+287%I?VT%[:S@%1/;74*3V\P4
M@%1+"Z2 $*1N(*KC%?D[)\?_ -B'_@K5\$O&_P"SMH/Q"CT[Q5XL\.R:C8>$
M_%FAR:%\3? GB/2'_M+1?&V@:%J;6^E^*+WPI?V]MJ-[-X)\0ZUITNE2:AI-
M_JEGI^I7AD_3GX:>$?\ A7_P]\$>!1K-]XAC\%^$O#GA.'7-4BLX-2U:'PWH
MUEHL>I:A%806ME'>WR6(N[I+:WB@2>:1(D6-4 #BQSH\E"#P7U#'4G5IXJC&
M-6%.=-.#H58PJSFX3O[2G/E;C/EC-.SL?)O[<'[>_P (_P!AOP;HNN>/K;5?
M$_B[QA_:T7@'X=^'1''K/B>70TT^76=1NM4N\:7X=\-:)'J=@-8UO4#-)$]_
M;1:9I^JW0FMD_/?4?VP/^"PEY\)%_:,T']E;]GBS^$U]X>_X3_3_  >]YXJ\
M2?%:W\ 7&EPZ[9ZMJ6C0?$C0;J^G&AO]NGL-*T:+Q/+"\<B>$;6YWV*_G[_P
M<":)X@?]J'X::GJEC=MX+U_]GNP\.^'-0$30V<VKZ'X_\>77CC2XIUF+#4(+
M+Q%X1O+W8EM)]@U#2I+>8O;RNOZ#?L1?\%F_V=_%?P^\#?#3]HO6HO@G\3O#
M6DZ)X.G\3:]97$7PJ\7#3(&TC3O$%AXITY+Z#P5=WEI965WKFG>-8?#VDZ7?
MW@M](U_4[1 T0>NLK^KY/@<RHX&EF7MYRGC'-UY2P\(S?+2C"A5BZ?-"G/GK
M.$W>4>?D7)S?=G_!.?\ ;27]N3X%3_$R_P!#T+PKXO\ #7BS4/!GC+P[X<U>
M\UG1X-0M;#3=9TO5]-NK^WM[R/3?$&C:O9WMO9SF\EL94N;5M0O?*\YON_5-
M4L=&M+G4]4O+73M,L+6>\O[^^GAM+*QL[:-Y[J\O;NXDBM[6SM8(WGN;F>6.
M&WAC>65TC5F'QW^RI^R/X"_9I\9?M#>._AIXFN+_ ,*?M)>/M+^)UEX-LK+3
MK;P=X(8VNI-/#X/N+&XN_MNG:[<:S->B19(-.M+&#2M-T2QL].L8E9G_  4%
M_9C\4_M<_LQ^,_@KX.\90>"]?UC4?#NMZ=<ZC%>2^']<G\-:I'JR^&/%!T^5
M;V'0]<:%('OH(+\Z/J46GZS)I6LPV4NEW8>%56$JXUJE-X?"5:T+2DI2^K4Z
MC@YQ:G[T_8.4H.3^)0YEH?(OC'_@J_9_%7Q=K7P?_P"">OP>\2?M;_%:RTN;
M5Y?$CR6O@7X*:%H]O<1V4VN7OBKQ%J6B:AK]@EU-#'82VR>'_#WB%[FW31/&
M-TPF1/A_P#_P6]_:"^%?QKF^%_[<'P)\)^$=-TW79/#WCB?X?:%XPT#QK\.9
MW,;0:V_AG7/%'C6S\=Z!%!+'?/'HNH:/>:GX?E&N^$;OQ9</INBZM^@O_!*G
M]B3QC^Q+\*/B;=?&T^#+/XG_ !(\76^K:[+X2U^;6O#F@>!?"FE?9O#.DS:]
M?:%X:\^Z35]4\:>(-1OC80VZ6VNZ=92W$TUC*]?@I_P6;^,OP3^,_P"U7H7B
M?X)>./"?Q&L=#^$>A^!/&VN>"[ZUU715\7:5XT\:WEI8Q:W#:RZ;KU[INE:I
MID4MSI-YJ]G:17EE;"4-!- H?19;@<KQV9XC+:5!XC+U"M"EFBJ8A8B52-.$
MHU4U[.A"$YN?+2<$U"-KRDY,_LX\+^)M%\9>']"\6>&M2MM8\-^)]%TSQ#H&
MKV;&2SU71=:LX-0TK4K.0@-):7]C<PW5NY52T4JDJI)4=#7P5_P2_O;K4/V!
M?V7I[QQ));_#:+2[8X/[K3-&US6=(TBW&7D4BUTJQLK8&)W@(BS;.T!C)^]:
M#Y:M3=&M6HM\SHUJM)R6B;IU)PO;I?EO\S\[_P!M+X>1_%#XH?L6^$[H0-I1
M_:!F\0:TER)A#-I?@SP;K/BNZMB(TVR/>'2+>TCAED2)WE^T3"X@M'MI?R'^
M"]GIO[4?_!0OX@_$CQS$USX+\,>)/&WQ:\0VU\ZM9GP9\,8[30?!"7 <00BV
M@6V\$[[64)-+:6TWVF*6-;U3^Z7QNU:PTGXX_LEB_EAMTUGQY\2] MY9CM!O
MM3^#_B?[)$I(*[KF6$6Z(>'=U4!F(4_A1^Q5IFIZ5:_M_P"EZ=*8?%VE_ #X
M@Z1:1Q1&*Y@GTW6-8L-3\B.:V\^16GLK.&5951HC%;XMG,[&+AKI2Q<(OWH_
M6L/*<4K\SH82K.G%*Z7O.4MU)<T8RM?1_P!8>$N)Q,/#3C.I&N\+BJ/!V2\*
MY9B[M5,OR[Q!\5JV6\0YA0FGS4K<T*5:I2Y>5T\/&;:BDO@_XQ_%KQ%\;/B9
MXR^+GB28W=WXRUJ\U6SMW%N4T_PYYLD7AC1;=HE"/;:+X=BTK3EE=WENGMI+
MII"TK+7TE^SS^R-%^T/\(?C'KOASQ/#JOQD\#2V,7P[^#VC:IX6M-<UV-)89
M-8U;Q!;>*-5T*V@T2\,D]CHNH6^JQ/;W6D7KW%Q<;K+1]0^)E^6WMW5;D+^Z
M1A&T5Q)YDB QJ@>*X65GVDHH1S(,E6+,I;1T_4]6T'4;75]&UK4]"US2KE9;
M+4]/N+C1M9TBZ \H_9KNSGM]0LKC:S0DPRP/M9XY%9<@>/'$P=:K7JTYXB-1
MU-9/EDO:P:C;F2BI1CJHRE=QCI:RM_H+GO#F9/AW <.\!<08?A#&Y"\G>4VP
M,,QPL\NR2KAUA\GS'!PJT\5'*,PI82E@\RQ&%I0Q<X3Q'L*_/5K(^PO"G_!.
MS]KCQ1J[P:[\.3\-_#%L3=ZYXQ\<^)O"&E>&/#6B8>;5M9O8X-9U#6[R"RM;
M9KRXM]/TB62181'=O:0*\T7RW\19-1A\97_AV[^)'_"S+/PE!<^$_!?BV'5)
M]6T36/ OAW6]0@TB_P#!TUWB[/A5[G4WGMHHY[JRM[S4)UMKBYMF@D.SXH^-
M'Q@\>VXTKQO\5?B?XYT:-U\[1?%_C[Q;K^C.R[5#1Z;JNL7FGNV$4^?-9OM;
MC]XSR,/LG]HYT\)?L1_L/?#9HH$U/Q+)\1/C+?H0\TEE%J]YJ*:1;2*J6UP6
M:T\7SVZW.3:NVDW#%;DM'.G7!4)PK1I4ZD(QH1J3G*4%*34E"-.4(\WNWM.,
M_:-MJW*KW/BJ&.\0,FXOX+CQMC.$,\QW%F:8W(,LR[AG(L1E>$X9P& R3'9U
MG.?T\RS?$9CG^+Q%54,!EU?+Z<\!E?L,6I..)J4,/3C^=$B;9RY<C+#S1%N*
MI@ EL?-ER1M)P &SD]J_K6_X)JQQQ_L9?!E(F+*%\=/C<K*IF^(_C"4IE  /
M+#A54@NN%1SO!K^3)9(G(=1M7"ELY#X8A6;:?O@$AF#LI4,[9R,U_6C_ ,$V
M8XD_8M^"BP#&^Q\6RN1&\>9I?B#XL>5R9(XGF99=Z27(39=2QR3(SHX:M,N_
MB3_PGX]]->RX'X.TB_\ C+L1RRO9I/(<1=Q6C:=D]KKFULTT?=[$ 9.< CIU
MZX_'-?SK?\%SOB+=_$?5OV8_V%/!>H^9XX^,GQ1\&>*M9TN-GA%G8:SXA?X5
M?"I]1FD^S1)::IX\\0:]XFADCO9/L-W\,89]1LA87@>;]7_VROVS?!_[&?@O
MP]XL\6?#KXK_ !,G\6:S?>']!T'X4^&K/7[V/4=/T>XU:2\\1W>HZII-AX=T
M%EB2T.K3RWC"\N88TLI@6*?RA:5^V3XTU#_@HKHG[='QO^ GQ*UOP]I7BF:[
MTWX9Z?H.NW5UX2\+6?A#6O G@*RT>_UG2;+2+_4?!E_JMAXHN+MDT>UU7Q8=
M5NK0:;>ZI;QCUS_/S(<%5E.MF/LTX8*A7JX9.5-.OC%&5.C&$)58N2I3DZLM
M$GRQ2=]5_6%IG[ W[%<.FZ;8/^RY\"-3CT[2-.TB#4M6^%O@_4-9N;'3M/CT
M^TEO]4O-'>_N+V2"&.2XNFFCGFN-UQ(?/(<?F7_P5Z_82^!VA?L=>)?B9\%/
M@[\,OAEXO^$_BKPYX\U;4/ ?@;PUX3N_$/@^>[F\+>*])U6^TBRL))=-L+3Q
M0?%[1W$DT,$GAXW9A:=?M,/[$?L[_'7PK^TE\*?"_P 8?!6C>,_#WASQ2-62
MTT?X@>'9_"OBVQN-#UB_T'4[;5]#GDG6W:'4].NUM;RSN[_3-4M!!J>F7UWI
MUY:W,OR/_P %)OVK_AY\ ?A'??#KQS\'?B?\99OCUX'^*7A'2_#?@31(=0T0
MVMKH.F:9K#^-];-['<>&-)DD\7Z3!:ZA::7J]_+(UW+I]E+)ITN X<NQ.,I9
MAA7"=6I5CB*;E2E6FHU%&:56$DZR@DXN:=W:*5]5'7^?3_@AA\?;+X8?M:7O
MPLU)X+?P_P#M#>$[GPY!)'YB6T7Q(\#0ZOXL\)RW9N(1%$;[PTOB_P .VLMA
M<SVU]J^JZ%IF5OKNRMY_[ _':/<>!_&,*R>6\OACQ% D@#-L>71;V.-@J+(Y
M8.P(5(I&8\*C-A3_ )U_PXB^+'PQ\<>!OB-X2\*^,M*\5_#WQ7X?\=>'KMO!
M?BS[/<:]X6O[3584N(39":^T^X&G)::G%YH-S927-I++$D@(_M0_8K_X*%>"
M?VZ;'Q;X"/PJ^+?PD^(/A_P+;:MXRL?%?A]X?"$D.N"/1[B;P-XS@82ZI'#=
M7BR646N:+X;UJ6U;[3%ILRV=\;8/H>+<"X9@LQI*$L/65-UI0J4I^SJTY0@Y
M.,*LI*,XVE?E:O&2;5T?R8?\$M&M[?\ ;K_8\O08Y))_&]DL&]#Y3)J7@#Q1
M:1_9F6:S*QQ07+/:R3)NDF1(GBN3(4?^_N,XC7!S@<YZX4@=.,$CGZ\=Q7^=
MQJOA3XO?L,_M$Z7IOBO3)O"GQ.^ WC_0-;T)=6MY+;2-6D\&ZM%=Z1XHTJ9$
M@M-3\'^-K!;&XBN].D$<NFWS6!2TNVNK*#^N+]A_]N[]IW]L+QGH5_?_ +'M
MU\)?@"_AK7+G6/C#K7C+5;Z'6O$=N;)?#UKX$TW6_"7@^XUO2=6=[HW-WIUM
MKUC90+YDFOK) ]O=@^*\+4K2PN84'2JX182C3=6->DG=<LDXP=3GJ<W.](1;
MBXS4DK.WY/?\'!_A[6M/^/W[.?BQK>Y/A[Q!\*?%/ARQO':!K"'6?"GC/^UM
M3@:/RVG2ZDTWQ?I31O(XAEBD9[<I);%)?KG_ (-[O$=I/\$/VB/"6^#^T=#^
M-VF>))(U;-P=.\5_#[PYI-K+*H<@1?;_  7K$,!**Y>&X=GDC>+'Z._\%#/V
M,-)_;8^ 6I_#U+G3]#^)'AN\_P"$O^$?BW4;>22UT3QG91&,Z=JTMNLETGA?
MQ?IC7/ACQ%Y,5R]E;W]OK]O8WNIZ%IL-?S#_ +(?QS^,_P#P24_:<\2V'[1G
MPD^(/ASP-XXTZV\*?$#PQ<0VB-?6FDZI/JNB?$/X<ZTCS>$?B WA*.[U2T$6
MD^)Y+/4M+\0:I;1:A8Z]'):($T*D,UX9EEU%P6.P%15I4)U(QEB:%.K.ISTH
MMQ<IQA4DE%/XHI-7DF?UE_MM7$-G^QU^U=/<-&D:?LV_&\(T@RHN)/AIXH@M
M5W<[7DN)(8TQ\S2,H7DU_&O_ ,$O_"VJ>+_V[OV8K32+*9CI7CN?QCJLPA\Z
M*#0_!_A77O$%[J$[RR6[6]L[65M:PRLT?E7FI6D9@G>5(9?UR_X*'?\ !47X
M8?M1?!O4_P!EC]BD?$+XU^-_C'!IVF>)]4\$> _%D9TOP9]J_M#6_#%CH>IZ
M5IGBW7/$/B>&PMM U2"PT4>'])\-:UJ]SJ?B".^@73&^FO\ @D9_P3>U[]ES
M3=8^.7QSL8+;XZ^.M!_X1_1_"PNK74F^%O@6[GL-3OM*O-0M"]M/XP\27MGI
MSZ\;2:YM-#TW2[+0]/NY'N]?DN@6"J_V-D&91Q:]GBLT<J.&PE1J-;V?LU0E
M7E3YG.---S:YHPYW%<JE&\E^S'BSQ3H?@?PEXD\9^)[MM.\-^$/#^K^)_$-_
M%:7NH/8:'H&GW.JZM>+8:;;WNIWQMM.M;BX%I86=U?7.P0VEM//)'$WXF_M9
M?\$\/@?_ ,%+?"'AG]K#]F7QSI'A+QUXX\-#4[+Q5/X?UJU\&_%^QAC_ +/T
MC_A8^@RPZ7XH\,>(?#\NF77AV7Q!#HDGB.!8FT7Q1X?UJ'1M+33/VF\?^&+;
MQCX&\9>#+D#[+XN\*^(O#%SD!E%OK^CWFD2DJX9&58KQMPD!3'W\*37\J'_!
M/#]OKQ%_P3ROM;_96_;"\+?$#PS\/+/7IF\+RW?AS4DUGX9^(M0UB\'B<)X?
MOUM=1UGX;^()=WBY;KP[#>WUKJEQJFK:/IWB&+Q/.-/#R<IH8WDQ&-RRK*.-
MP<H7H0<)5*^%JPDJJC1G).JHS45*,4VHRNG%JY^2?QJ^ OQX_9&^)UKX,^*O
MAK7_ (=_$/1+RU\6^#_$&DZC?C3KZ72[V)M+\:?#;QYI#6UOJ,-G>PVLT%UI
M-W;ZYX6OGMK37+31M3*VY_MP_P""=WQ\\3_M,_L?_!_XN>-5B_X335=*UWPW
MXON((5M;;4O$G@7Q)J_@O5-;AM4FGCLSKL^A_P!KW%DDLD=E>7MU:1.T,,9K
M\"O^"COQ_P!&_P""GWQ,^"?P9_8I^'?C?XU:G\.(?%.L:OXYL_#.J:-H-N?'
M]QX-TG[%_:.O0V-UX;\+:#/HEKJ?BWQ7XLTW0]!^WOH5GH=[?7\-R$_HQ_8T
M_9VMOV5/V:_A=\"H]9MO$5WX*T:]/B#Q!:6+Z;:ZYXH\0:OJ'B7Q+J=G9R2S
M36UA)K&KWD>F1S2O<IIL-H+AC/O #U>(<9'&9;E4\715'-[UE6IQ4(.&&C*4
M(3JPBG*+K37-"-23DG&32<?>?D7[1G@W]ES]NA_BW^QGXOUN:Y^)_P +=*\(
M^,M8CT_1=2TSQ9\,[[QG8->>"O&7A+7_ !!H</AOQ&);-A!KEEH.HZ]IMO::
MA'H7C"VL)]4L8F_EG_;6_P""6G[1'['D%UXR=;/XK_!"TNI0WQ2\&64\&H>%
M;2ZU2UMM.3XD>#+J4W7AB74Y[M8(-6T2]\3>%&N 4O=8T>YN]/TR?](O^"A_
MCWXW_L0?\%*-$_;%\"> _%7B#X=>)/AKX,TGQG/;V^LV'@#QCIT,-_X8\3?#
M[Q'XHLM,U/2-,\0P67A[P[XHT2;5P9-(O;+0M6ATS4+3[;#=^W?M2?\ !7S]
MD7XS_LC_ !#\ ?#A_&'C7XO?&_X;:U\.M%^#-WX'UAO$6BZ]XYLO^$9D_MZ\
M2SNO"=Y<>&SJC:U:Q^%M>UZZUFZLK6WT"&YNY ( G+:N:9=++Y8"J\5@,;&C
M.M"T)T\/6J25/%0JRE*+H2H\O/>;C3E34?=D]7X?_P $"?VB_'%[KOQ2_9<U
MR\O-8\%^'_!T'Q1^'D%P[26O@L6_B[3_  SXMT'3))I6GLM(UAO%&A:YI^B1
MQBSLM0L==N((K%M0E2?]G?V]OVNK;]B[]GO6OB__ ,([#XO\3W>L:+X-\">%
MKJ_DTO3]8\6>(6NS;2:I?0Q37$6CZ-IMCJ6NZLEK$+N\MM/&EV4UO?:C;2Q?
MG#_P1<_8-^(GP!L_&/[1?QAT:Z\&>-/B?X8M/"'A7P)JNGRV'B?1O!B:Y:Z[
MJ>K>*;.1\:/J/B;4M)T5K'09(_M]CI&F0W6JK;7NI&QL_MC_ (*E?LN^,OVJ
M_P!DW7_!7PZ6&\^(G@[Q%H?Q+\':+.Z0#Q+J?AJTUJRU+PS#=-)'';W^L:!K
MNK1:,UR6M/[;ATQ9C;(S7EN'%F"RVMQ(XPE3CET\5AX5YPF_9<UTL5.,E9*G
M*JKMQM%1D[62;/P;_9$\*?'?_@L%\;?&%K^U!\=?'EY\&?A9IV@^)/&?@KPA
MJW_"-^';S4_$%YK$'A;P=X;\)PX\.Z;:E].\0W-]XUN]'\1^*[;0]+;11XAF
MOM=L=5T7 _X+3?"#X6_ [XS_  2^''P@\#^$O 'A+2OV?+:>'PMX9LH-/2XD
M7X@>,;5-3U61'EU'5M1U$6L,4^OZY<7=]=R6\KW5_>W))M_D+]C']K'XO_L(
M?'#5]=T'P)?^*-8\0V'_  @7CWX)^(K?6/#6L:UJ(U.*\T;3$MX]&O?$.C^-
M] UN.0:;!_8E[(XU77-+FTR9]6AN;7Z1_P""H9_;-^+_ /PJ3]JG]H;]G^#X
M$^#=<T#4? 7@SP=I-]JWB;5_"5GINKQ:[IUU\5M4FL](_L7Q#XWF\5:I<^$]
M*U32-'GM[;PIJEO?:7IVKM$U\'U=*%3#\08;EJT:65.C5H8"E"M1@JE2=""L
MJ,&IUJTIIM5)QNH.*3BD^;^DO_@E@X;]@#]F)=\I$/@.]M@9S&TD@M/%WB6U
M68F,E0)O)WHA_>(FU)0)0XK]!*_G(_X(\?M _MI^*O!?P=^#FE? '09OV8/
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3ZTJ:=:%*52*E[*-2Z@G?39G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !G 04# 2(  A$! Q$!_\0
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M(KU&ZN(Q.(JRE4?Z^_\ !$?_ )/3_P"Z2>//_2OPU7]?=?R"?\$1_P#D]/\
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M?'QRO/\  2RO.\ J\9/ZKFF73JUYX+&TG"2JT)59N*=.7NJK&$?U]_X(C_\
M)Z?_ '23QY_Z5^&J_K[K^03_ ((C_P#)Z?\ W23QY_Z5^&J_K[I]/O\ S/\
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MG1Q5*G*@G"<;S5"55T)5J,Z=>BZ;YN:$8M_IC_P3^_;O^&7_  4!^!MO\6O
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M"_CC05E$DNA^([&)U+J"6DTW4[?9J.CW9%U8S*3+%+^OL?\ P4:_947]JO\
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MU5%%,_1O^(W^,W_1V/$?_P 33B+_ .>(?\.G_P!@[_HB9_\ "\^(O_S54?\
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;3E.I.4YR=Y3G)RE)V2NVVV]$DNB222222__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
